06 December 2024
The government allocated over 5 billion rubles for preferential lending to buy priority imported products. Launched in late 2022, this initiative offers affordable financing for essential foreign products. The list includes drugs containing insulin, antibiotics, various types of medical devices and other medical goods.
Funds will be distributed to credit institutions and VEB.RF to offset losses from issuing preferential loans to importers. This measure supports existing loans of about 140 billion rubles, ensuring favorable terms for borrowers.
The total amount of state support for this program in 2024 will amount to 14.6 billion rubles from the federal budget. The main goal of the funding is to stimulate the import of priority goods through the mechanism of affordable lending to enterprises. The implementation of the program and the targeted use of budget funds will be monitored by the Ministry of Industry and Trade, which is ordered to submit a report on the results to the government by early February 2025.
PrintMerry Christmas and Happy New Year!
28 December 2024
NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024
28 November 2024
05 November 2024
17 new drugs added to the list of vital and essential drugs
23 January 2025
Sechenov University has opened its Representative Office in Hangzhou (China)
23 January 2025
A Moscow region manufacturer of blood collection systems is expanding its capacity
22 January 2025
A biotechnology and medicine center has opened in Mordovia
22 January 2025